AMP-99 MANAGEMENT CO LLC 4
4 · Talecris Biotherapeutics Holdings Corp. · Filed Oct 8, 2009
Insider Transaction Report
Form 4
AMP-99 MANAGEMENT CO LLC
10% Owner
Transactions
- Sale
Common Stock
2009-10-06$19.00/sh−6,945,946$131,972,974→ 15,707,155 total(indirect: By LLC)
Footnotes (2)
- [F1]Talecris Holdings, LLC sold 27,052,632 shares of the Issuer's common stock in the Issuer's initial public offering. Following the sale, Talecris Holdings, LLC owns 61,175,236 shares of the Issuer's common stock.
- [F2]Ampersand 1999 Limited Partnership ("Fund 1"), Ampersand 1999 Companion Fund Limited Partnership ("Fund 2"), Ampersand 2001 Limited Partnership ("Fund 3"), Ampersand 2001 Companion Fund Limited Partnership ("Fund 4"), and Ampersand Plasma Holdings, L.L.C. ("Fund 5") (collectively referred to as the "Funds"), own a 25.7% equity interest in Talecris Holdings, LLC. AMP-99 Management Company Limited Liability Company ("AMP-99 MC LLC") is the General Partner of Fund 1 and Fund 2, AMP-01 Management Company Limited Liability Company ("AMP-01 MC LLC") is the General Partner of Fund 3 and Fund 4, and Fund 3 is the Managing Member of Fund 5 (AMP-99 MC LLC, AMP-01 MC LLC and the Funds collectively referred to as the "Ampersand Entities"). Each of the Ampersand Entities disclaims beneficial ownership of the securities reported herein, except to the extent of its respective pecuniary interest.